Prescription medication · Tricyclic Antidepressant (TCA)

doxepin

Also sold as Sinequan, Silenor. Doxepin is used to treat insomnia, which means you have trouble staying asleep.

Data updated 2026-05-15

9,780
FDA reportsLightly reported
3
InteractionsFew interactions
$0.08
Generic price (NADAC)

What the data shows

doxepin (Sinequan) is a prescription Tricyclic Antidepressant (TCA), reported less often than most tracked drugs (9,780 FDA reports), with 3 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

doxepin (Sinequan) is a prescription Tricyclic Antidepressant (TCA). Doxepin is used to treat insomnia, which means you have trouble staying asleep.

Doxepin is a medicine that can help you stay asleep. It belongs to a class of drugs called tricyclic antidepressants.

Drug Pricing (NADAC)

Generic Price

$0.08/unit

Generic Available

Yes (28 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: DOXEPIN 10 MG CAPSULE

Same CMS presentation as the headline generic unit price above (3 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +2.4% vs prior release.

10¢11¢ 2024-022024-052024-12 7.56¢
Effective NADAC / unit vs prior NDCs
February 21, 2024 $0.0996/EA - 1
May 22, 2024 $0.0738/EA -25.9% 1
December 18, 2024 $0.0756/EA +2.4% 23
View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Doxepin is used to treat insomnia, which means you have trouble staying asleep.

Common side effects

Feeling sleepy or drowsy, Feeling sick to your stomach, Upper respiratory tract infection (like a cold)

Key warnings

After taking doxepin, some people have done things like driving a car while not fully awake.

The sections below are summarized in plain English from doxepin's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Doxepin works by affecting certain natural chemicals in the brain that help regulate sleep. It helps to keep you asleep throughout the night. It is a low dose formulation of a tricyclic antidepressant.

Side Effects (from patient reports)

Based on 9,780 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for doxepin, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for doxepin each year to the FDA Adverse Event Reporting System (FAERS).

05001,0001,500 199820062009201220152018202120242025 567

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where doxepin sits

doxepin has more FDA adverse-event reports than 38% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is doxepin; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 9,780 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 1998–2025.

Total Reports

9,780

Reports Mentioning Death

1,746

17.9% of reports — not proof of cause

Hospitalization Reports

2,865

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 6,137 (68%)
Male 2,822 (31%)

Age Distribution

0–17 197
18–44 1,803
45–64 2,890
65–74 998
75+ 756

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 TOXICITY TO VARIOUS AGENTS 801
3 COMPLETED SUICIDE 613
4 FATIGUE 599
5 NAUSEA 557
6 PAIN 527
7 HEADACHE 482
8 PRURITUS 468
10 DIARRHOEA 431
11 DYSPNOEA 418
12 INSOMNIA 417
13 CHRONIC KIDNEY DISEASE 408
14 DIZZINESS 405
15 ANXIETY 401
16 DEPRESSION 392
17 FALL 382

Reactions in Death Reports

COMPLETED SUICIDE 613
TOXICITY TO VARIOUS AGENTS 591
DEATH 363
DRUG ABUSE 201
CARDIO-RESPIRATORY ARREST 156
OVERDOSE 79
PULMONARY OEDEMA 70
CARDIAC ARREST 67
BRAIN OEDEMA 54
DRUG INTERACTION 52

Reactions in Hospitalization Reports

TOXICITY TO VARIOUS AGENTS 278
FALL 216
NAUSEA 211
DYSPNOEA 208
FATIGUE 193
PAIN 176
DIARRHOEA 171
ASTHENIA 169
DRUG INTERACTION 164
HEADACHE 163

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

After taking doxepin, some people have done things like driving a car while not fully awake. You might not remember doing it. This can be dangerous, so tell your doctor right away if this happens. Doxepin may also worsen depression or cause suicidal thoughts. Tell your doctor if you notice any new or worsening symptoms of depression.

Known Drug Interactions

( 4.2 ) Cimetidine: Increases exposure to doxepin. 7.2 Cimetidine Doxepin exposure is doubled with concomitant administration of cimetidine, a nonspecific inhibitor of CYP isozymes. A maximum dose of 3 mg is recommended in adults and elderly when cimetidine is co-administered with doxepin [see Clinical Pharmacology (12.3 )] 7.3 Alcohol When taken with doxepin, the sedative effects of alcohol may be potentiated [ see Warnings and Precautions (5.2 , 5.4 )].

Mechanism: Cimetidine blocks the enzymes that normally break down doxepin, which causes the amount of doxepin in your body to double.

Examples: amitriptyline, desipramine, doxepin, imipramine, nortriptyline.

Mechanism: Doxepin can increase how strongly your body reacts to dopamine. This can lead to unexpected changes in your heart rate or blood pressure.

( 7.1 ) Doxepin: Increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with doxepin. Doxepin The AUC 0-inf and C max of ramelteon increased by approximately 66% and 69%, respectively, upon coadministration of doxepin with ramelteon. Patients should be closely monitored when ramelteon is coadministered with doxepin [see Clinical Pharmacology (12.5) ] .

Mechanism: Taking doxepin can raise the levels of ramelteon in your body by slowing down its breakdown.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I drink alcohol while taking doxepin?
No, do not drink alcohol while taking doxepin. It can make you feel even more sleepy.
What should I do if I feel more depressed after starting doxepin?
Tell your doctor right away if you feel more depressed or have thoughts of harming yourself.
Can I drive after taking doxepin?
Doxepin can make you sleepy and less alert. Avoid driving or operating heavy machinery after taking it.
How long does it take for doxepin to start working?
Doxepin should help you stay asleep through the night. Talk to your doctor if you still have trouble sleeping after 7 to 10 days.
Can I take doxepin with other sleep medicines?
Talk to your doctor before taking doxepin with other medicines that make you sleepy, like antihistamines or other sleep aids.
What if I accidentally take too much doxepin?
Seek medical attention immediately.
Can I stop taking doxepin suddenly?
Talk to your doctor before stopping doxepin. Stopping suddenly can cause withdrawal symptoms.
Is doxepin addictive?
It is not known if doxepin is addictive. Talk to your doctor if you have concerns.
Does doxepin interact with any other medications?
Yes, doxepin can interact with certain medications, including MAO inhibitors and cimetidine. Tell your doctor about all the medicines you take.
What should I do if I experience side effects?
Tell your doctor if you experience any side effects while taking doxepin.
What are the common side effects of doxepin?
The registry lists Feeling sleepy or drowsy, Feeling sick to your stomach, Upper respiratory tract infection (like a cold) among the most-reported FAERS reaction terms for doxepin. The compiled record contains 9,780 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does doxepin interact with other medications?
The registry has 3 documented interaction rows for doxepin. Notable source-record pairings include cimetidine, dopamine, ramelteon. These rows are not a complete medication review.
What drug class is doxepin?
doxepin belongs to the Tricyclic Antidepressant (TCA) drug class. It requires a prescription (Rx). Doxepin is used to treat insomnia, which means you have trouble staying asleep.
What pregnancy or breastfeeding source fields are listed for doxepin?
The FDA label for doxepin contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near doxepin - same-class peers and common alternatives.

Compare doxepin vs acamprosate side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for doxepin: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on doxepin

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for doxepin

The FDA label for doxepin (sold under brand names such as Sinequan, Silenor) classifies it as a prescription-only medication in the Tricyclic Antidepressant (TCA) class. Doxepin is used to treat insomnia, which means you have trouble staying asleep. Official labeling lists 3 commonly reported side effects, including Feeling sleepy or drowsy, Feeling sick to your stomach, Upper respiratory tract infection (like a cold).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 9,780 voluntary reports. The database also lists 3 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $0.08.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: December 24, 2024

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page